AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

What's Your Reaction?







Or register with email
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
News Oct 5, 2024 0
News Oct 5, 2024 0
Total Vote: 48
contact.kartavyanews@gmail.comTotal Vote: 45
YesTotal Vote: 55
Yes